CSL Behring Commitment

For more than 100 years, CSL Behring has specialized in plasma therapies to improve the lives of patients with bleeding disorders, immune deficiencies, inherited emphysema, and other conditions.

CSL Behring offers many programs and services to the bleeding disorders community, in addition to its range of blood products. Some of these include:

  • Sponsoring programs and activities that benefit people with bleeding disorders
  • Working with government authorities to help make sure patients have access to care
  • Improving and expanding educational and outreach efforts
  • Funding medical research
Featured programs and services of the CSL Behring Commitment include:
  • Gettin' in the GameSM Gettin' in the GameSM was started by CSL Behring to encourage kids with bleeding disorders to be physically active. This program is the only national competition in golf and baseball for children with bleeding disorders. It is designed to provide them with the opportunity to learn about the fundamentals of both sports, reinforce the importance of physical fitness, and help them foster connections with their peers. More>>
  • Gettin' in the GameSM Junior National Championship The JNC is the only national competition in golf and baseball for children aged 7-18 years with bleeding disorders. More>>
  • Reimbursement Resource Center Call 1-800-676-4266 for expert advice and information about insurance matters, including health insurance reimbursement for CSL Behring products. More>>
  • Patient Assistance Program This program provides medically necessary therapies to qualified patients who are uninsured, underinsured, or who cannot afford their prescribed therapy. More>>
  • VWD Consumer Advisory Committee CSL Behring hosts meetings with patients who have VWD and parents to keep current on the needs and interests of the VWD community, and to provide a forum for consumers to exchange ideas.

For more information about any of the programs and services offered by CSL Behring, call our Consumer Affairs Center at 1-888-508-6978.

Important Safety Information

Stimate® (desmopressin acetate) Nasal Spray, 1.5 mg/mL is a treatment used to stop some types of bleeding in people with mild hemophilia A or mild to moderate von Willebrand disease (VWD) Type 1. Stimate Nasal Spray should not be used in children under 11 months of age.

All patients using Stimate Nasal Spray are at risk of water intoxication, fluid overload and low sodium levels in the blood. Follow your healthcare provider’s instructions on limiting the amount of fluid you drink when using Stimate Nasal Spray, as too much fluid intake can lead to serious adverse reactions, including seizures, coma, and even death. Fluid restrictions are especially important for children and elderly patients, as they are at higher risk for these reactions.

See the patient information leaflet in the prescribing information for Stimate Nasal Spray for symptoms that could mean your blood sodium level is low—including headache, hallucinations, confusion, restlessness, weight gain and muscle spasms. Immediately report any of these symptoms to your physician or, if necessary, an emergency department. Also contact your doctor immediately if you have uncontrolled bleeding.

Before being prescribed Stimate Nasal Spray, make sure your doctor knows about all your medical conditions and about any medications you are taking. Use Stimate Nasal Spray exactly as your healthcare provider has instructed.

Side effects of Stimate Nasal Spray generally come from having too much water in the body. The most common include facial flushing, nasal congestion, runny nose, nose bleed, sore throat, cough, and upper respiratory infections. Tell your healthcare provider if you experience a side effect that does not go away.

Please see full prescribing information for Stimate Nasal Spray

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.